Further gene therapy technology with the ELEVECTA producer cell line

22 Jan 2024

Delivering on the promise of adeno-associated virus (AAV)-based gene therapies beyond rare diseases will require large quantities of high-quality AAV. In this application note, explore how the Cytiva ELEVECTA® producer cell line is produced in a robust manner, and is a stable cell line for inducible AAV production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s genome and requires only a single induction step to initiate AAV production.

Links

Tags

Cell Lines Stem Cells and Primary CellsPrimary cell cultures, established cell lines and stem cells are vital for <i>in vitro</i> and <i>ex vivo</i> experimentation. High-quality cells, optimized for your applications, alongside optimized cell substrates, growth medium and supplements, are critical for experimental success. Explore a range of cells suitable for your applications, including isogenic cell lines, competent cells, induced pluripotent stem cell (iPSC)-derived cell lines, fungal/bacterial/mammalian cell lines, stem cells and cancer cell lines. Find the best cells for your research in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Cell Line Development
Further gene therapy technology with the ELEVECTA producer cell line